A comparison of drug and surgery costs distinguishes payer spending from a patient's bill. This study compared reported health care costs in claims for anterior lumbar interbody fusion [1].
What the claims showed
The study compared patients with evidence of semaglutide use (n = 425) with matched controls (n = 2,514). The claims definition required evidence of at least a year of continuous use before surgery. It did not verify whether a patient took the medicine around surgery [1].
The semaglutide group had stays about 0.6 days shorter, same-day costs about $10,400 lower and 90-day costs about $9,700 lower. The results did not show a statistically clear difference in the complications examined [1].
What could affect the estimates
A separate study of hospital stays after spine surgery also used matched records. Neither design can account for every difference in patients or procedures.
The estimates describe medical claims. They do not predict a patient's bill or establish that semaglutide caused the differences.